Skip to content

NuProbe vs OncoDNA

NuProbe logo

NuProbe

Focused Genomics Panels

25 employees · est. 2016 · Houston, United States

VS
OncoDNA logo

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases

52 employees · est. 2014 · Belgium

OncoDNA is the older company (2016 vs 2014); OncoDNA is the larger of the two.

Side-by-Side Comparison

NuProbe OncoDNA
Founded
2016 2014 older
Headquarters
Houston, United States Belgium
Employees
25 52 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Series B Series C
Total Funding
$103.00M $35.38M
Funding Rounds
4 3
Services
Assay Development, High-Sensitivity Genomics Panels, Low-Abundant Sequence Variant Detection, Biopharma Services, Custom Assay Development OncoDEEP Kit, OncoSELECT Kit, OncoXPLORE Kit, Clinical Testing, Precision Enrollment, Clinical Data Intelligence (OncoCDI), Automated Library Preparation, OncoKDM Software, Project Care
Target Customers
Clinical and Research Laboratories, Biopharmaceutical Companies, Oncology Researchers, Precision Medicine Practitioners Oncology Professionals, Laboratory Professionals, Pharma Companies, Healthcare Institutions, Biopharma Companies, Researchers
Taxonomy
GenomicsMolecular DiagnosticsDNA BiomarkersCNVsGene FusionsLow-Frequency Mutations +8 GenomicsPrecision MedicineTheranosticsCancer TreatmentGenetic DiseasesBiomarker Testing +8
Website
nuprobe.com oncodna.com
NuProbe logo

About NuProbe

NuProbe, founded in 2016, is a biotechnology startup headquartered in the United States. The company specializes in the development and validation of high-sensitivity genomics panels. Their focus is on challenging DNA biomarkers such as CNVs, gene fusions, and low-frequency mutations. Positioned wi...

OncoDNA logo

About OncoDNA

OncoDNA, founded in 2012 in Belgium, is a prominent player in the Biotechnology and Health Care industries. Specializing in precision medicine, this genomic and theranostic company focuses on enhancing cancer and genetic disease treatments. Their slogan, "Genomic and theranostic company specializing...

Also comparing in this category

Comparing more than these two?

Get NuProbe, OncoDNA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does NuProbe compare?

A PDF of NuProbe and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

NuProbe was founded in 2016, based in Houston, United States, with 25 employees. NuProbe, founded in 2016, is a biotechnology startup headquartered in the United States. The company specializes in the development and validation of high-sensitivity genomics panels. Their focus is o. OncoDNA was founded in 2014, based in Belgium, with 52 employees. OncoDNA, founded in 2012 in Belgium, is a prominent player in the Biotechnology and Health Care industries. Specializing in precision medicine, this genomic and theranostic company focuses on enhancin.
NuProbe has raised $103.00M and OncoDNA $35.38M. Latest stage: NuProbe Series B, OncoDNA Series C.
Both work in Biotechnology and Health Care and list genomics and molecular diagnostics among their focus areas.

Compare NuProbe with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at NuProbe on 12 Sep 2024, and OncoDNA on 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout